The Relationship of Hemoglobin A1c and Diabetic Wound Healing



Status:Terminated
Conditions:Podiatry, Diabetes, Diabetes, Diabetes, Diabetes
Therapuetic Areas:Endocrinology, Orthopedics / Podiatry
Healthy:No
Age Range:18 - Any
Updated:12/14/2017
Start Date:February 2012
End Date:March 2014

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The purpose of this study is to investigate the relationship of hemoglobin A1c in diabetic
wound healing. Additionally, a comparison of two wound dressings, AmeriGel® (Amerx Health
Care Corp., Clearwater, FL) and Bacitracin, with and without vitamin C supplementation, will
be done to evaluate impact on time to wound closure.

This is a prospective randomized controlled study evaluating the relationship of hemoglobin
A1c in diabetic wound healing. Length of time for wound closure will be compared using four
treatment options.

Inclusion Criteria:

- >18 years of age

- Diabetic (Type I and Type II)

- Ulceration of the foot at least one centimeter in width/length

- Ulceration at least 0.2 centimeters in depth

Exclusion Criteria:

- Ulceration width/length > 7.5 centimeters

- Wound depth > 1.25 centimeters

- Purulent, excessive drainage and/or other signs of infection (i.e. erythema, edema,
warmth)

- Inability to provide informed consent

- Inability to swallow pills (vitamin C supplement)

- Patients with concurrent renal problems

- Patients with medication contraindications to Vitamin C and/or topical wound dressings
We found this trial at
1
site
Penn State Milton S. Hershey Medical Center
500 University Dr
Hershey, Pennsylvania 17033
(717) 531-6955
Penn State Milton S. Hershey Medical Center Penn State Milton S. Hershey Medical Center, Penn...
?
mi
from
Hershey, PA
Click here to add this to my saved trials